Jaguar Animal Health Inc (JAGX) - Total Liabilities
Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) has total liabilities worth $53.19 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore JAGX net asset momentum to track the company's year-over-year net asset growth rate.
Jaguar Animal Health Inc - Total Liabilities Trend (2007–2025)
This chart illustrates how Jaguar Animal Health Inc's total liabilities have evolved over time, based on quarterly financial data. See JAGX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Jaguar Animal Health Inc Competitors by Total Liabilities
The table below lists competitors of Jaguar Animal Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reklaim Ltd
V:MYID
|
Canada | CA$821.02K |
|
Nevada Sunrise Gold Corp
V:NEV
|
Canada | CA$129.67K |
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
Thailand | ฿169.31 Million |
|
Lucapa Diamond Company Ltd
AU:LOM
|
Australia | AU$2.88 Million |
|
Manchester and London Investment Trust plc
LSE:MNL
|
UK | GBX13.78 Million |
|
Novakand Pharma AB (publ)
ST:LARK
|
USA | Skr1.24 Million |
|
Gibb River Diamonds Ltd
AU:GIB
|
Australia | AU$196.15K |
|
PAVmed Inc
NASDAQ:PAVM
|
USA | $12.28 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Jaguar Animal Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jaguar Animal Health Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jaguar Animal Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jaguar Animal Health Inc (2007–2025)
The table below shows the annual total liabilities of Jaguar Animal Health Inc from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $57.01 Million | +21.48% |
| 2024-12-31 | $46.93 Million | +2.32% |
| 2023-12-31 | $45.87 Million | -6.03% |
| 2022-12-31 | $48.81 Million | +17.86% |
| 2021-12-31 | $41.41 Million | +61.51% |
| 2020-12-31 | $25.64 Million | -0.37% |
| 2019-12-31 | $25.74 Million | -27.82% |
| 2018-12-31 | $35.66 Million | +35.23% |
| 2017-12-31 | $26.37 Million | +338.20% |
| 2016-12-31 | $6.02 Million | -24.84% |
| 2015-12-31 | $8.01 Million | +71.79% |
| 2014-12-31 | $4.66 Million | +543.60% |
| 2013-12-31 | $724.11K | -85.22% |
| 2007-12-31 | $4.90 Million | -- |
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more